Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.
2.

Laparoscopic grasper for intramedullary biopsy: a technique to improve tissue sampling.

Xia Z, Takano AM, Sittampalam K, Howe TS.

Singapore Med J. 2014 Aug;55(8):e116-8.

3.
4.

FDG hepatic superscan caused by massive breast cancer invasion.

Tichelaar V, Gemmel F, de Rhoter W, Bronkhorst C, de Graaf H.

Clin Nucl Med. 2009 Oct;34(10):716-8. doi: 10.1097/RLU.0b013e3181b53f43.

PMID:
19893412
5.

Hepatic tuberculosis mimics metastasis revealed by 18F-FDG PET/CT.

Wang X, Shi X, Yi C, Chen Z, Zhang B, Zhang X.

Clin Nucl Med. 2014 Jun;39(6):e325-7. doi: 10.1097/RLU.0000000000000263.

PMID:
24152632
6.

Detection of Diffuse Infiltrative Primary Hepatic Lymphoma on FDG PET-CT: Hallmarks of Hepatic Superscan.

Mahajan S, Kalra S, Chawla M, Dougall P.

World J Nucl Med. 2016 May-Aug;15(2):142-4. doi: 10.4103/1450-1147.167581.

7.

Multiple hepatic lesions in a case of isolated hepatic tuberculosis simulating metastases on 18F-FDG PET/CT imaging.

Karunanithi S, Sharma P, Jain TK, Vijay MK, Kumar R.

Nucl Med Rev Cent East Eur. 2014;17(2):108-9. doi: 10.5603/NMR.2014.0027.

8.

18F-FDG hepatic superscan in a patient with chronic myeloid leukemia.

Du B, Li X, Li N, Li Y, Hsu B.

Clin Nucl Med. 2014 Sep;39(9):835-6. doi: 10.1097/RLU.0000000000000413.

PMID:
24662659
9.

18F-FDG PET and PET/CT in diagnosis and treatment monitoring of pyrexia of unknown origin due to tuberculosis with prominent hepatosplenic involvement.

Shejul Y, Chhajed PN, Basu S.

J Nucl Med Technol. 2014 Sep;42(3):235-7. doi: 10.2967/jnmt.113.132985. Epub 2014 Jun 19.

10.
11.

Validation of FDG uptake in the arterial wall as an imaging biomarker of atherosclerotic plaques with 18F-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT).

Bucci M, Aparici CM, Hawkins R, Bacharach S, Schrek C, Cheng S, Tong E, Arora S, Parati E, Wintermark M.

J Neuroimaging. 2014 Mar-Apr;24(2):117-23. doi: 10.1111/j.1552-6569.2012.00740.x. Epub 2012 Aug 28.

PMID:
22928741
12.

Low positive yield from routine inclusion of the brain in whole-body 18F-FDG PET/CT imaging for noncerebral malignancies: results from a large population study.

Manohar K, Bhattacharya A, Mittal BR.

Nucl Med Commun. 2013 Jun;34(6):540-3. doi: 10.1097/MNM.0b013e32836066c0.

PMID:
23503001
13.

(18)F-FDG hepatic superscan caused by a non-germinal center subtype of diffuse large B-cell lymphoma.

Yang G, Nie P, Wang Z, Xing X.

Eur J Nucl Med Mol Imaging. 2016 Sep;43(10):1928. doi: 10.1007/s00259-016-3399-0. Epub 2016 May 3. No abstract available.

PMID:
27138332
14.

Focal fat spared area in the liver masquerading as hepatic metastasis on F-18 FDG PET imaging.

Purandare NC, Rangarajan V, Rajnish A, Shah S, Arora A, Pathak S.

Clin Nucl Med. 2008 Nov;33(11):802-5. doi: 10.1097/RLU.0b013e318187ef32. No abstract available.

PMID:
18936622
17.

Diffuse intense 18F-FDG uptake at PET in unilateral breast related to breastfeeding practice.

Ko KH, Jung HK, Jeon TJ.

Korean J Radiol. 2013 May-Jun;14(3):400-2. doi: 10.3348/kjr.2013.14.3.400. Epub 2013 May 2.

19.

Diffuse pulmonary uptake on FDG-PET with normal CT diagnosed as intravascular large B-cell lymphoma: a case report and a discussion of the causes of diffuse FDG uptake in the lungs.

Wagner T, Brechemier D, Dugert E, Le Guellec S, Julian A, Hitzel A, Beyne-Rauzy O.

Cancer Imaging. 2012 Jan 23;12:7-12. doi: 10.1102/1470-7330.2012.0002.

20.

Hepatic adenomatosis may mimic metastatic lesions of liver with 18F-FDG PET/CT.

Sanli Y, Bakir B, Kuyumcu S, Ozkan ZG, Gulluoglu M, Bilge O, Turkmen C, Mudun A.

Clin Nucl Med. 2012 Jul;37(7):697-8. doi: 10.1097/RLU.0b013e3182443ced.

PMID:
22691518

Supplemental Content

Support Center